Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Q3 Revenues Increase 145 Percent but Loss Widens

NEW YORK (GenomeWeb News) – MDxHealth said today that revenues in the third quarter rose 145 percent year over year, driven by a 141 percent increase in commercial revenues.

For the three months ended Sept. 30, MDxHealth's total revenues increased to €925,000 ($1.2 million) from €378,000 a year ago, as its commercial revenues climbed to €644,000 from €267,000.

The firm, based in Liege, Belgium, and with offices in Irvine, Calif., did not disclose its expenses for the third quarter. Its net loss for the period increased to €2.3 million from €1.9 million a year ago.

MDxHealth finished the quarter with €13.9 million in cash and cash equivalents.

Highlights in the third quarter included accreditation by the College of American Pathologists, as well as the expansion of an existing deal with Merck KGaA to include MDxHealth's PredictMDx for Glioblastoma test. The company also raised $12.4 million in July in a private placement.

In May, MDxHealth launched its ConfirmMDx for Prostate Cancer test. Today, CEO Jan Groen said the firm is "very pleased with the acceptance" of the test among urologists in the US "as evidenced by our sales growth."

"Based on the favorable market reception, it is clear that our epigenetic test provides urologists with valuable information to help address false-negative biopsy concerns with their patients," he added. "This early success gives me confidence that ConfirmMDx will also deliver value for the company and its shareholders."

The company said that its health economic study for the test, which will provide cost comparison data, is scheduled to be submitted for publication. It didn't provide a timeline for that submission.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.